Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003060 · ClinicalTrials.gov registry record · Phase 1
Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Metastatic Melanoma
A Phase 1 study, sponsored by Louisiana State University Health Sciences Center Shreveport.
- Terminated
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT00003060: Clinical Trial Phase 1 study, sponsored by Louisiana State University Health Sciences Center Shreveport.
NCT00003060 is a Phase 1 study that was terminated before completion, run by Louisiana State University Health Sciences Center Shreveport. The registered enrollment target is 6 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00003060, a Phase 1 study, was terminated before completion, sponsored by Louisiana State University Health Sciences Center Shreveport.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with bone marrow transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. PURPOSE: Clinical trial to study the effectiveness of chemotherapy plus bone marrow transplantation in treating patients with metastatic melanoma that has not responded to previous therapy.
Interventions
- DRUG cyclophosphamide
- DRUG methotrexate
- BIOLOGICAL filgrastim
- DRUG busulfan
- DRUG cyclosporine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 1995-03 |
| Est. Completion | 2001-02-22 |
| Phase | Phase 1 |
Why NCT00003060 stopped before completion
NCT00003060 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 5 interventions - of which cyclophosphamide is the first listed.
NCT00003060 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00003060 about?
NCT00003060 is a clinical study titled "Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Metastatic Melanoma". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with bone marrow transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. PURPOSE: Clinical trial to study...
What is the current status of trial NCT00003060?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 1995-03. Estimated completion is 2001-02-22.
What interventions are being tested in trial NCT00003060?
The interventions under investigation include: cyclophosphamide (DRUG), methotrexate (DRUG), filgrastim (BIOLOGICAL), busulfan (DRUG), cyclosporine (DRUG).
Who is sponsoring clinical trial NCT00003060?
This trial is sponsored by Louisiana State University Health Sciences Center Shreveport, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00003060's enrollment target sits among peer trials
6 1974th of 2000 higher than 12 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia